About


This database has been compiled by Inocul8 and GALVmed with the intention of gaining a better understanding of the breadth and complexity of the veterinary vaccine market globally. The results are provided within this website to act as a resource for other parties with an interest in the animal health industry, for both identification of existing livestock vaccines in any given field, and discovery of market needs and development opportunities for new vaccine products.


Database development methodology


Database content was originally derived from desk-based research using information from publically-accessible sources including published literature, regulatory agency databases and manufacturer websites. Direct input from manufacturers was sought where information was difficult to obtain by other means.

GALVmed and Inocul8 are continuing to develop the database, ideally through direct input from the veterinary vaccine community. If you would like to submit details relating to additional products, or amendments to existing entries, please visit our contact page to download a submission form.

 

GALVmed


The Global Alliance for Livestock Veterinary Medicines (GALVmed) is a not-for-profit organization founded in 2005, and is supported by the Bill & Melinda Gates Foundation and the UK Department for International Development. GALVmed's mission focuses on making livestock vaccines, diagnostics, and medicines accessible and affordable to the millions for whom livestock is a lifeline. GALVmed is currently working on nine different disease-preventing technologies across four disease areas, namely East Coast Fever, Rift Valley Fever, Porcine Cysticercosis, and Newcastle Disease.


Inocul8


Inocul8 is a company focused on the translation of world leading academic research into high impact vaccines for livestock. The company works alongside the Moredun Research Institute (MRI) to enhance their capacity in the development of vaccines from the Institute's output and to act as a route for commercial development of the emerging technologies. Currently Inocul8 is working on vaccines for Caseous Lymphadenitis, Haemonchus and Haemorrhagic Septicaemia. Inocul8 is partially funded through the European Regional Development Fund.

© 2010 Vetvac.org   I   Terms and Conditions